Disclosure-shy industry
Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
WTO gives India a clean chit
Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review
Intellectual Property: Why is India silent, as a compromise deal on COVID-19 therapies is worked out
The fact is, Indian and South African interests have diverged; India is not in desperate need of vaccines anymore and hence does not want to …
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
AI throws patent system into turmoil — especially in drug discovery
Artificial intelligence is overturning the conventional idea of intellectual property rights
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
Wooing the judges, openly
There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators
US pharma strikes back
Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …
Encouraging orphan drugs in India
India needs to formulate an atrractive law to spur development of drugs for rare diseases
Hypocrisy of the west
A legitimate tool to meet any public health crisis, rich countries, particularly the US, have resolutely opposed its deployment by developing …
What drives innovation?
The new Intellectual Property Rights policy is based on a tenuous premise that having more IPRs will result in more innovation
A treaty too many
India is learning that there is a heavy price to be paid for the large number of bilateral investment treaties, or BITs, it has signed in the …
क्या मेडिकल पेटेंट का भयावह इतिहास रच रही है दवा कंपनी फाइजर?
दवाओं को वैश्विक बौद्धिक संपदा व्यवस्था में लाना फाइजर की अगुवाई में कॉर्पोरेट धोखाधड़ी की जीत थी
New ruse in Big Pharma's old game
Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics
दवा की बड़ी कंपनियों की लाॅबिंग के पीछे का कड़वा सच
अमेरिकी दवा कंपनियां चाहती हैं कि कोविड-19 वैक्सीन या दवाओं को बौद्धिक संपदा अधिकार के दायरे से बाहर रखने की भारत की मांग को ...